جاهز للتشغيل
جاهز للتشغيل
A new study has revealed that the drug combination used to slow down aging, which combines Dasatinib and Quercetin, may cause unexpected damage to the brain, particularly demyelination and increased harm to the corpus callosum. Experiments on mice showed that the damage was greater in smaller animals, which is surprising and raises warnings about self-medicating with this combination outside of medical supervision, despite its rising popularity among researchers seeking to extend lifespan.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading